Clinical trial
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally…
NCT00139269 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00139269 |
|---|---|
| Title | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Official title | Phase I/II Pilot Study of Induction Chemotherapy With Docetaxel in Combination With Cisplatin and 5-Fluorouracil (5-FU) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Sanofi Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck, SSCHN |
| Intervention type | Drug |
| Interventions | Docetaxel, Cisplatin, 5-Fluorouracil |
| Enrollment | 38 |
| Start date | Feb 1, 1998 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Jun 4, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: